Khalil Katato
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 7
- Cancer Diagnosis and Treatment 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Nathan R. Wall (2 shared papers)Ayad Al‐Katib (2 shared papers)Ramzi M. Mohammad (2 shared papers)Mahmoud Barbarawi (4 shared papers)Babikir Kheiri (4 shared papers)Ghassan Bachuwa (5 shared papers)Yazan Zayed (4 shared papers)Nayera Hamdy (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Blood (1 paper)Biological Chemistry (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)The American Journal of Gastroenterology (1 paper)
- Partner nations
- United StatesJordanLebanon
In The Last Decade
Khalil Katato
15 papers receiving 169 citations
Peers
Comparison fields: 5 of 50
- Internal Medicine 35
- Genetics 49
- Physiology 8
- Pathology and Forensic Medicine 29
- Pharmacology 26
Countries citing papers authored by Khalil Katato
This map shows the geographic impact of Khalil Katato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Katato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Katato more than expected).
Fields of papers citing papers by Khalil Katato
This network shows the impact of papers produced by Khalil Katato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Katato. The network helps show where Khalil Katato may publish in the future.
Co-authors
The 25 scholars most cited alongside Khalil Katato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model. | 1996 | 35 |
| 2 | Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies. | 1998 | 32 |
| 3 | 1998 | 27 | |
| 4 | 2019 | 25 | |
| 5 | 2019 | 20 | |
| 6 | 2019 | 11 | |
| 7 | 2018 | 5 | |
| 8 | 2012 | 3 | |
| 9 | 2020 | 3 | |
| 10 | 2017 | 3 | |
| 11 | 2020 | 2 | |
| 12 | 2011 | 2 | |
| 13 | 2020 | 2 | |
| 14 | 2010 | 1 | |
| 15 | 2018 | 1 | |
| 16 | 2022 | 0 | |
| 17 | 2013 | 0 | |
| 18 | 2012 | 0 |
About Khalil Katato
Khalil Katato is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 18 papers that have together received 172 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Renal cell carcinoma treatment (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Cancer Diagnosis and Treatment (3 papers), Multiple and Secondary Primary Cancers (3 papers), Cancer Treatment and Pharmacology (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Internal Medicine (35 citations), Genetics (49 citations), Physiology (8 citations), Pathology and Forensic Medicine (29 citations) and Pharmacology (26 citations). Khalil Katato has collaborated with scholars based in United States, Jordan and Lebanon. Frequent co-authors include Nathan R. Wall, Ayad Al‐Katib, Ramzi M. Mohammad, Mahmoud Barbarawi, Babikir Kheiri, Ghassan Bachuwa, Yazan Zayed, Nayera Hamdy, Adam Chahine and Ramzi M. Mohammad. Their work appears in journals such as Journal of Clinical Oncology, Blood, Biological Chemistry, Journal of Cancer Research and Clinical Oncology and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.